Supplemental Corticosteroids for Dental Patients with Adrenal

Total Page:16

File Type:pdf, Size:1020Kb

Supplemental Corticosteroids for Dental Patients with Adrenal DENTISTRY & MEDICINE ABSTRACT Background. Dental patients with pri- mary or secondary adrenal insufficiency, or AI, may be A D A at risk of experiencing J ✷ ✷ adrenal crisis during or C N O after invasive procedures. O N I Since the mid-1950s, sup- T T Supplemental I A N U C I U plemental steroids in A N G E D R 3 corticosteroids for rather large doses have TICLE been recommended for patients with AI to prevent adrenal crisis. dental patients with Methods. To evaluate the need for sup- plemental steroids in these patients, the adrenal insufficiency authors searched the literature from 1966 to 2000 using MEDLINE and textbooks for Reconsideration of the information that addressed AI and adrenal crisis in dentistry. Reference lists of rele- problem vant publications and review articles also were examined for information about the topic. CRAIG S. MILLER, D.M.D., M.S.; JAMES W. LITTLE, Results. The review identified only four D.M.D., M.S.; DONALD A. FALACE, D.M.D. reports of purported adrenal crisis in den- tistry. Factors associated with the risk of adrenal crisis included the magnitude of or more than 50 years, medicine and dentistry surgery, the use of general anesthetics, the have appreciated the importance of the adrenal health status and stability of the patient, glands in maintaining physiological integrity. and the degree of pain control. This appreciation grew from studies1,2 in the Conclusions. The limited number of 1930s that demonstrated that adrenocortical reported cases strongly suggests that Finsufficiency was associated with electrolyte disturb- adrenal crisis is a rare event in dentistry, ances, and a decade later3 that cortisol prevented hypo- especially for patients with secondary AI, volemia and circulatory collapse associ- and most routine dental procedures can be ated with adrenalectomy. During the performed without glucocorticoid Adrenal crisis is 1940s, organic chemists isolated and supplementation. Clinical Implications. The authors a rare event in elucidated the structures of 28 steroids 4 identify risk conditions for adrenal crisis dentistry, from the adrenal cortex. It was against this background that Hench and col- and suggest new guidelines to prevent this and most leagues5,6 reported the beneficial effects problem in dental patients with AI. routine dental of cortisone in the treatment of diseases procedures can other than adrenocortical insufficiency be performed (for example, rheumatoid arthritis). without These findings ushered in the era of glu- became the standard of care for many 8 glucocorticoid cocorticoid therapy for patients with pri- years. mary adrenal insufficiency, or AI, and Although these recommendations have supplementation. inflammatory connective-tissue disease. served as important guidelines, knowl- The concept of secondary AI evolved edge of the adrenal cortical response to in the early 1950s from reports of patients experiencing physical stressors has been refined refractory hypotension at the end of routine surgical during the past 30 years.9-11 Based on procedures and dying hours later as a consequence of these more recent findings, reconsidera- glucocorticoid therapy withdrawal and resultant AI.7,8 tion of the guidelines for perioperative These outcomes resulted in a list of recommendations glucocorticoid supplementation in den- for perioperative glucocorticoid supplementation that tistry appears needed. We consider gluco- 1570 JADA, Vol. 132, November 2001 Copyright ©1998-2001 American Dental Association. All rights reserved. DENTISTRY & MEDICINE corticoid supplementation in dentistry by ad- istered at a target equal to, or less than, the dressing AI, current medical recommendations, normal daily output of cortisol (that is, 20 to 30 adrenal crisis and identification of risk in den- milligrams per day).18 For example, hydrocorti- tistry, and prescribing guidelines for periopera- sone, which has the equivalent anti-inflammatory tive coverage. potency of cortisol, usually is administered at 20 mg/day; prednisone and prednisolone, which ADRENAL INSUFFICIENCY have four times the anti-inflammatory potency of The adrenal cortex produces mineralocorticoids cortisol, usually are administered at 5 mg/day; and glucocorticoids that are important in main- and dexamethasone, which has 25 times the taining fluid volume. Cortisol, the principal glu- anti-inflammatory potency of cortisol, is admin- cocorticoid, maintains extracellular fluid, istered at 0.75 mg/day. whereas aldosterone, the principal mineralocorti- Such regimens, when administered as a coid, regulates salt and water balance.12 Insuffi- morning dose, are less suppressive because of cient production of these hormones can result the diurnal rhythm of cortisol secretion, from primary or secondary adrenal disease. Pri- resulting in highest levels in the morning. mary adrenocortical insufficiency, also known as Higher and divided daily doses are more sup- Addison’s disease, is uncommon, occurring in pressive, and often begin producing clinical man- about eight people per million population per ifestations of glucocorticoid excess (that is, year, with a prevalence of about 40 to 100 per Cushing’s syndrome) after three weeks of use.20 million.13-15 Although the level of cortisol production in It is caused by a progressive destruction of the patients with secondary AI due to hypothalamic adrenal cortex, usually of an idiopathic nature or pituitary disease can be low because of its (most commonly autoimmune), but also results dependence on the level of circulating ACTH, the from hemorrhage, sepsis, infectious diseases administration of corticosteroids alone does not (such as tuberculosis, human immunodeficiency determine which patients secrete sufficient virus, cytomegalovirus and fungal infection), levels of cortisol in response to stress. For malignancy, adrenalectomy, amyloidosis or example, the average cortisol production rate in drugs.16 Clinical evidence of the deficiency gener- patients with Cushing’s syndrome has been ally arises only after 90 percent of the adrenal reported to be 36 mg/day.21 cortices have been destroyed.17 Affected patients The table presents the signs and symptoms have high levels of adrenocorticotropic hormone, associated with AI and corticosteroid treatment. or ACTH, in blood, and a very low to undetect- The manifestations of primary AI (Addison’s dis- able level of aldosterone and cortisol in blood. ease) relate to a deficiency of aldosterone and Cortisol levels during this disease do not cortisol. The most common complaints are weak- increase in response to stress and ACTH. ness, fatigue and nausea. The most common sign Secondary adrenocortical insufficiency results is melanin hyperpigmentation of the skin and from hypothalamic or pituitary disease, or from mucous membranes. Hypotension, anorexia, the administration of exogenous corticosteroids. fever and weight loss are common findings. Although classified together, these two entities In secondary AI, the severity of symptoms is have different physiological effects. In the ab- often less marked, and normal mineralocorticoid sence of hypothalamic or pituitary function, the function is preserved. The preservation of miner- adrenal cortex undergoes irreversible atrophy.18 alocorticoid function makes it less likely for In contrast, long-term administration of cortico- patients with secondary AI to experience adrenal steroids blunts adrenal cortical function, with crisis than it is for patients with primary AI. variable and reversible effects.19 Cases of Cushing’s syndrome, which is due to chronic glu- hypothalamic-pituitary disease are less common cocorticoid excess, produces several features rec- than those induced by use of corticosteroids. Re- ognizable to the dentist, including plethora (red searchers estimate that 5 percent of adults in the face), moon face, hirsutism, acne, capillary United States regularly use corticosteroids20 and fragility and bruising, hypertension, osteoporosis are at risk of developing secondary adrenocor- and muscle weakness. tical insufficiency. Depending on the inflammatory condition, ADRENAL CRISIS corticosteroids in medicine generally are admin- The most significant acute adverse outcome of AI JADA, Vol. 132, November 2001 1571 Copyright ©1998-2001 American Dental Association. All rights reserved. DENTISTRY & MEDICINE TABLE FEATURES OF ADRENAL INSUFFICIENCY. VARIABLE PRIMARY ADRENAL SECONDARY ADRENAL CUSHING’S SYNDROME ADRENAL CRISIS INSUFFICIENCY INSUFFICIENCY Underlying Glucocorticoid and Glucocorticoid Potential glucocor- Severe glucocorticoid Problem mineralocorticoid deficiency due to ticoid insufficiency deficiency with or deficiency due to hypothalamic or due to long-term without mineralo- destruction or pituitary disease administration of corticoid deficiency due atrophy of corticosteroid for to stress (for example, adrenal gland inflammatory surgery, infection) and condition or organ inability of adrenal transplantation cortex to meet demand Clinical Weakness, Similar to Cushingoid Major categories: Features fatigability, weight primary adrenal features: weight dGastrointestinal loss, hypotension insufficiency gain, moon face, (nausea, vomiting, (may be ortho- except less thin skin, buffalo diarrhea, stomach static), hyperpig- dramatic, no hump (that is, fat cramps) mentation of skin, hyperpigmenta- pad on neck), dHypotension, weak mucous mem- tion and patients central obesity, pulse, profuse branes and creases; tend not to be acne, bruisability, sweating, weak- less common are salt-depleted hypertension
Recommended publications
  • Salivary 17 Α-Hydroxyprogesterone Enzyme Immunoassay Kit
    SALIVARY 17 α-HYDROXYPROGESTERONE ENZYME IMMUNOASSAY KIT For Research Use Only Not for use in Diagnostic Procedures Item No. 1-2602, (Single) 96-Well Kit; 1-2602-5, (5-Pack) 480 Wells Page | 1 TABLE OF CONTENTS Intended Use ................................................................................................. 3 Introduction ................................................................................................... 3 Test Principle ................................................................................................. 4 Safety Precautions ......................................................................................... 4 General Kit Use Advice .................................................................................... 5 Storage ......................................................................................................... 5 pH Indicator .................................................................................................. 5 Specimen Collection ....................................................................................... 6 Sample Handling and Preparation ................................................................... 6 Materials Supplied with Single Kit .................................................................... 7 Materials Needed But Not Supplied .................................................................. 8 Reagent Preparation ....................................................................................... 9 Procedure ...................................................................................................
    [Show full text]
  • Cortisol Deficiency and Steroid Replacement Therapy
    Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Cortisol deficiency and steroid replacement therapy This leaflet explains about cortisol deficiency and how it is treated. It also contains information about how to deal with illnesses, accidents and other stressful events in children on cortisol replacement. Where are the The two most important ones are: adrenal glands and • Aldosterone – this helps regulate what do they do? the blood pressure by controlling how much salt is retained in the The adrenal glands rest on the tops body. If a person is unable to of the kidneys. They are part of the make aldosterone themselves, they endocrine system, which organises the will need to take a tablet called release of hormones within the body. ‘fludrocortisone’. Hormones are chemical messengers that switch on and off processes within the • Cortisol – this is the body’s natural body. steroid and has three main functions: The adrenal glands consist of two parts: - helping to control the blood the medulla (inner section) which sugar level makes the hormone ‘adrenaline’ which is part of the ‘fight or flight’ - helping the body deal with stress response a person has when stressed. - helping to control blood pressure the cortex (outer section) which and blood circulation. releases several hormones. If a person is unable to make cortisol themselves, they will need to take a tablet to replace it. Pituitary gland The most common form used is hydrocortisone, but other forms Parathyroid gland may be prescribed. Thyroid gland Medulla Cortex Adrenal Thymus gland Gland Kidney Adrenal gland Pancreas Sheet 1 of 7 Ref: 2014F0715 © GOSH NHS Foundation Trust March 2015 What is In these circumstances, the amount cortisol deficiency? of hydrocortisone given needs to be increased quickly.
    [Show full text]
  • 1970Qureshiocr.Pdf (10.44Mb)
    STUDY INVOLVING METABOLISM OF 17-KETOSTEROIDS AND 17-HYDROXYCORTICOSTEROIDS OF HEALTHY YOUNG MEN DURING AMBULATION AND RECUMBENCY A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN NUTRITION IN THE GRADUATE DIVISION OF THE TEXAS WOI\IIAN 'S UNIVERSITY COLLEGE OF HOUSEHOLD ARTS AND SCIENCES BY SANOBER QURESHI I B .Sc. I M.S. DENTON I TEXAS MAY I 1970 ACKNOWLEDGMENTS The author wishes to express her sincere gratitude to those who assisted her with her research problem and with the preparation of this dissertation. To Dr. Pauline Beery Mack, Director of the Texas Woman's University Research Institute, for her invaluable assistance and gui­ dance during the author's entire graduate program, and for help in the preparation of this dissertation; To the National Aeronautics and Space Administration for their support of the research project of which the author's study is a part; To Dr. Elsa A. Dozier for directing the author's s tucly during 1969, and to Dr. Kathryn Montgomery beginning in early 1970, for serving as the immeclia te director of the author while she was working on the completion of the investic;ation and the preparation of this dis- sertation; To Dr. Jessie Bateman, Dean of the College of Household Arts and Sciences, for her assistance in all aspects of the author's graduate program; iii To Dr. Ralph Pyke and Mr. Walter Gilchrist 1 for their ass is­ tance and generous kindness while the author's research program was in progress; To Mr. Eugene Van Hooser 1 for help during various parts of her research program; To Dr.
    [Show full text]
  • CORTISOL IMBALANCE Patient Handout
    COMMON PATTERNS OF CORTISOL IMBALANCE Patient HandOut Cortisol that does not follow the normal pattern can trigger blood sugar imbalances, food cravings and fat storage, especially around the middle. Related imbalances of low DHEA commonly result in loss of lean muscle, lack of strength, decreased stamina and low exercise tolerance. Chronically Elevated Cortisol Overall higher than normal cortisol Lifestyle suggestions: production throughout the day from • Reduce stress and improve coping skills prolonged stress demands. High • Protein at each meal, no skipping lunch cortisol also depletes its precursor hormone progesterone. • Hydrate throughout the day, herbal teas and water, avoid soft drinks General symptoms: • Reduce consumption of refined carbohydrates and caffeine • Food/sugar cravings • Get adequate sleep (at least 7 hours); catnaps • Feeling “tired but wired” • Aerobic exercise: <40 min low – moderate intensity • Insomnia during time when cortisol level within optimal range • Anxiety • Strength training: with guidance 2-3 times per week • Enjoy exercise that decreases excessive stress symptoms Steep Drop in Cortisol • Exercise in the morning Stress/fatigued pattern – morning Lifestyle suggestions: cortisol in the high normal range or • Reduce stress and improve coping skills elevated, but levels drop off rapidly, • Protein at each meal, no skipping lunch indicating adrenal dysfunction. • Hydrate throughout the day, herbal teas General symptoms: and water, avoid soft drinks • Mid-day energy drop • Reduce consumption of refined carbohydrates and caffeine • Drowsiness • Get adequate sleep (at least 7 hours); catnaps • Caffeine/sugar cravings • Exercise mid morning to boost energy with a combination • Low exercise tolerance/ of muscle building and cardiovascular activities poor recovery • Schedule more time for fun activities Rebound Cortisol Up and down/ irregular cortisol, Lifestyle suggestions: not following the normal pattern.
    [Show full text]
  • Sleep Deprivation on the Nighttime and Daytime Profile of Cortisol Levels
    Sleep. 20(10):865-870 © 1997 American Sleep Disorders Association and Sleep Research Society Sleep Loss Sleep Loss Results in an Elevation of Cortisol Levels the Next Evening Downloaded from https://academic.oup.com/sleep/article/20/10/865/2725962 by guest on 30 September 2021 *Rachel Leproult, tGeorges Copinschi, *Orfeu Buxton and *Eve Van Cauter *Department of Medicine, University of Chicago, Chicago, Illinois, U.S.A.; and tCenter for the Study of Biological Rhythms and Laboratory of Experimental Medicine, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium Summary: Sleep curtailment constitutes an increasingly common condition in industrialized societies and is thought to affect mood and performance rather than physiological functions. There is no evidence for prolonged or delayed effects of sleep loss on the hypothalamo-pituitary-adrenal (HPA) axis. We evaluated the effects of acute partial or total sleep deprivation on the nighttime and daytime profile of cortisol levels. Plasma cortisol profiles were determined during a 32-hour period (from 1800 hours on day I until 0200 hours on day 3) in normal young men submitted to three different protocols: normal sleep schedule (2300-0700 hours), partial sleep deprivation (0400-0800 hours), and total sleep deprivation. Alterations in cortisol levels could only be demonstrated in the evening following the night of sleep deprivation. After normal sleep, plasma cortisol levels over the 1800-2300- hour period were similar on days I and 2. After partial and total sleep deprivation. plasma cortisol levels over the 1800-2300-hour period were higher on day 2 than on day I (37 and 45% increases, p = 0.03 and 0.003, respec­ tively), and the onset of the quiescent period of cortisol secretion was delayed by at least I hour.
    [Show full text]
  • 18-Dehydrogenase Deficiency W
    Arch Dis Child: first published as 10.1136/adc.51.8.576 on 1 August 1976. Downloaded from Archives of Disease in Childhood, 1976, 51, 576. Hypoaldosteronism in three sibs due to 18-dehydrogenase deficiency W. HAMILTON, A. E. McCANDLESS, J. T. IRELAND, and C. E. GRAY From the University Departments of Child Health, Liverpool and Glasgow Hamilton, W., McCandless, A. E., Ireland, J. T., and Gray, C. E. (1976). Archives of Disease in Childhood, 51, 576. Hypoaldosteronism in three sibs due to 18-dehydrogenase deficiency. Three sibs all presented in the early neonatal period with a salt-losing syndrome. The salt-losing form of congenital adrenal hyperplasia was diagnosed and appropriate treatment with glucocorticosteroids, mineralocorticosteroids, and additional dietary salt started. Although early life was maintained with difficulty, with age all3 children required decreasingamounts ofreplace- ment steroids to maintain normal plasma electrolyte balance. They were reinvestigated at the ages of 15 years and 8 years (twins), when cortisol synthesis and metabolism proved normal, but aldosterone synthesis was blocked by deficiency of 18-dehydro- genase. Rational treatment of these cases of a salt-losing syndrome in which aldo- sterone synthesis alone is blocked due to lack of the enzyme 18-dehydrogenase requires the administration of a mineralocorticosteroid drug only. Since deoxycor- ticosterone (acetate or pivalate) requires intramuscular administration, as life-long therapy oral fludrocortisone is preferable. Although fludrocortisone has glucocorti- coid activity, the 'hydrocortisone equivalent' effect of the small dosage used was un- likely to inhibit either pituitary corticotrophin or growth hormone production. Salt-loss of adrenal origin is recognized as a female external genitalia or macrogenitosomia http://adc.bmj.com/ feature of 3/1-hydroxysteroid dehydrogenase de- praecox in the male.
    [Show full text]
  • Quantification of the Hormones Progesterone and Cortisol in Whale
    Quantification of the Hormones Progesterone and Cortisol in Whale Breath Samples Using Novel, Non-Invasive Sampling and Analysis with Highly-Sensitive ACQUITY UPLC and Xevo TQ-S Jody Dunstan,1 Antonietta Gledhill,1 Ailsa Hall,2 Patrick Miller,2 Christian Ramp3 1Waters Corporation, Manchester, UK 2Scottish Oceans Institute, University of St. Andrews, UK 3Mingan Island Cetacean Study, St Lambert, Quebec, Canada APPLICATION BENEFITS INTRODUCTION ■■ Provides a novel, non-invasive sampling method The conservation and management of large whale populations require information to obtain sample from whale blow. These about all aspects of their biology, life history, and behavior. However, it is samples can then be analyzed to determine extremely difficult to determine many of the important life history parameters, the levels of progesterone and cortisol. such as reproductive status, without using lethal or invasive methods. As such, efforts are now focused on obtaining as much information as possible from the ■■ A sensitive, repeatable, quantitative LC-tandem quadrupole MS method is shown. samples collected remotely, with a minimum of disturbance to the whales. Various excreted samples, such as sloughed skin and feces are being used to determine ■■ Parallel acquisition of MRM and full scan sex and maturity, as well as life history stage.1,2 MS data allows both the compounds of interest, and also the matrix background Attention has recently shifted more towards what can be analyzed from samples to be monitored. of whale blow for health assessment3 or steroid hormone analysis.4 Hormone analysis is of particular interest as high levels of progesterone can be used as an ■■ Simultaneous quantitative and investigative indicator of pregnancy status, while other steroids, such as glucocorticoids may be analysis can be performed for different markers of the short-term, acute stress response.
    [Show full text]
  • Progesterone – an Amazing Hormone Sheila Allison, MD
    Progesterone – An Amazing Hormone Sheila Allison, MD Management of abnormal PAP smears and HPV is changing rapidly as new research information is available. This is often confusing for physicians and patients alike. I would like to explain and hopefully clarify this information. Almost all abnormal PAP smears and cervical cancers are caused by the HPV virus. This means that cervical cancer is a sexually transmitted cancer. HPV stands for Human Papilloma Virus. This is a virus that is sexually transmitted and that about 80% of sexually active women are exposed to. The only way to absolutely avoid exposure is to never be sexually active or only have intercourse with someone who has not had intercourse with anyone else. Because most women become sexually active in their late teens and early 20s, this is when most exposures occur. We do not have medication to eradicate viruses (when you have a cold, you treat the symptoms and wait for the virus to run its course). Most women will eliminate the virus if they have a healthy immune system and it is then of no consequence. There are over 100 subtypes of the HPV virus. Most are what we call low-risk viruses. These are associated with genital warts and are rarely responsible for abnormal cells and cancer. Two of these subtypes are included in the vaccine that is now recommended prior to initiating sexual activity. Few women who see me for hormone management will leave without a progesterone prescription. As a matter of fact, I have several patients who are not on any estrogen but are on progesterone exclusively.
    [Show full text]
  • Internal Hcpcs Code Description Charge Charge Number Lab 10001 84060 Acid Phosphatase #829642 68.5 10002 82040 Albumin Sera 69.5
    INTERNAL HCPCS CODE DESCRIPTION CHARGE CHARGE NUMBER LAB 10001 84060 ACID PHOSPHATASE #829642 68.5 10002 82040 ALBUMIN SERA 69.5 10003 84075 ALKALINE PHOSPHATASE 52.5 10004 82150 AMYLASE 7 80.5 10009 82088 ALDOSTERONE, SERUM #004374 498 10011 86060 ASO TITER #006031 119.5 10013 84600 ALCOHOL, METHYL #017699 219 10014 87116 AFB CULTURE AND SMEAR/ #183753 165 10015 86901 BLOOD TYPING-RH (D) 23 10016 87206 ACID FAST STAIN #008618 73 10017 82247 TOTAL BILIRUBIN 50.5 10018 86900 BLOOD TYPING-ABO 23 10019 85002 BLEEDING TIME 50.5 10020 84520 BUN 43.5 10022 82607 VITAMIN B-12 115 10026 82310 CALCIUM,TOTAL 39 10027 85025 CBC W/COMP DIFF 69.5 10028 82380 CAROTENE #001529 138.5 10029 82435 CHLORIDE SERUM 80.5 10030 82465 CHOLESTEROL 50.5 10032 82550 CPK, TOTAL 67.5 10033 82565 CREATININE 44.5 10034 82575 CREATININE CLEARANCE #003004 80.5 10035 82378 CEA #002139 169 10036 87070 CULTURE SPUTUM & GRAM STAIN 51.5 10037 82552 CPK ISOENZYMES #002154 123.5 10038 82355 CALCULUS ANALYSIS #120790 142 10039 82382 CATECHOLAMINES,RANDOM URINE #316203 179.5 10040 82533 CORTISOL,TOTAL 175.5 10041 85007 DIFFERENTIAL 22 10044 80162 DIGOXIN/LANOXIN LEVEL 152 10045 80185 DILANTIN, QUANT 105.5 10048 P9016 PRBC'S 326.5 10050 36430 BLOOD ADMINISTRATION 262.5 10051 86022 PLATELETS APHERESIS 1112 10054 83700 ELECTROPHORESIS, LIPOPROTEIN #235036 165 10055 83020 ELECTROPHORESIS, HEMOGLOBIN 82.5 10056 80307 ETHANOL, QUANT. 173.5 10057 87106 FUNGAL ID #390 167 10058 86780 FTA-ABS #006379 118 10059 82746 FOLATE (FOLIC ACID) SERUM 68.5 10062 82941 GASTRIN SERUM #004390 95.5 10063 87205 GRAM STAIN 42 10064 85014 HCT 28 10065 85018 HEMOGLOBIN 28 10066 84702 HCG, QUANT.
    [Show full text]
  • Hydrocortisone Tablets Contain Lactose Monohydrate
    New Zealand Data Sheet 1. PRODUCT NAME Hydrocortisone 5 mg Tablets Hydrocortisone 20 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each Hydrocortisone 5 mg Tablet contains 5 mg of hydrocortisone. Each Hydrocortisone 20 mg Tablet contains 20 mg of hydrocortisone. Excipient(s) with known effect Hydrocortisone Tablets contain lactose monohydrate. For the full list of excipients, see Section 6.1. 3. PHARMACEUTICAL FORM Hydrocortisone 5 mg Tablet: white, round, biconvex tablet having a diameter of 6.5 mm. Hydrocortisone 20 mg Tablet: white, round, biconvex tablet having a diameter of 7.94 mm, breakline on one face and dp logo on the other. The score line on Hydrocortisone 20 mg Tablet is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4. CLINICAL PARTICULARS 4.1. Therapeutic indications • Replacement therapy in Addison’s disease or chronic adrenocortical insufficiency secondary to hypopituitarism. • Inhibition of the secondary increase in ACTH secretion when aminoglutethimide is administered for breast or prostatic cancer. 4.2. Dose and method of administration Dose As replacement therapy The normal requirement is 10‐30 mg daily (usually 20 mg in the morning and 10 mg at night to mimic the circadian rhythm of the body). 1 | Page As combination therapy with aminoglutethimide A dosage of 40 mg daily, given as 10 mg with breakfast, 10 mg with dinner and 20 mg at bedtime is usually recommended. Special populations Elderly population Steroids should be used cautiously in the elderly, since adverse effects are enhanced in old age, see Section 4.4. When long term treatment is to be discontinued, the dose should be gradually reduced over a period of weeks or months, depending on dosage and duration of therapy, see Section 4.4.
    [Show full text]
  • Medicine, St. Louis, Mo.) 17-Hydroxycorticosteroids Of
    BINDING OF CORTICOSTEROIDS BY PLASMA PROTEINS. III. THE BINDING OF CORTICOSTEROID AND RELATED HORMONES BY HUMAN PLASMA AND PLASMA PROTEIN FRAC- TIONS AS MEASURED BY EQUILIBRIUM DIALYSIS 1, 2 BY WILLIAM H. DAUGHADAY WITH THE TECHNICAL ASSISTANCE OF IDA KOZAK (From the Metabolism Dizision, Department of Medicine, Washington University School of Medicine, St. Louis, Mo.) (Submitted for publication September 30, 1957; accepted December 5, 1957) The physical state of the corticosteroid hor- drawn, although little loss of binding affinity occurred mones in human plasma has been under investi- after storage at -10° C. The conditions of dialysis were the same as previously reported (2). Usually 10 ml. of gation in this laboratory. Dialysis equilibrium ex- plasma in a cellophane bag (Visking nojax, 18/32 casing) periments have been reported which show that the was dialyzed against 40 ml. of Krebs phosphosaline buf- 17-hydroxycorticosteroids of plasma are bound to fer, pH 7.4 (4), in a large test tube. Where a high de- plasma proteins to an extent of more than 90 per gree of binding was anticipated, 80 ml. of buffer was cent (2). Of the plasma protein fractions tested used. In several experiments where the amount of plasma or plasma protein fraction was limited, 5 ml. of protein for their cortisol binding power with high con- solution was dialyzed against 40 ml. of buffer. The ra- centrations of cortisol, albumin had the greatest dioactive and nonradioactive steroids were included in binding affinity. The importance of albumin was the dialysis buffer by diluting an alcoholic solution of apparently further supported by equilibrium pa- the steroids with buffer.
    [Show full text]
  • Steroid-Induced Iatrogenic Adrenal Insufficiency in Children
    Review Steroid-Induced Iatrogenic Adrenal Insufficiency in Children: A Literature Review Shogo Akahoshi * and Yukihiro Hasegawa Division of Endocrinology and Metabolism, Tokyo Metropolitan Children’s Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo 183-8561, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-42-300-5111 Received: 12 October 2020; Accepted: 5 December 2020; Published: 9 December 2020 Abstract: The present review focuses on steroid-induced adrenal insufficiency (SIAI) in children and discusses the latest findings by surveying recent studies. SIAI is a condition involving adrenocorticotropic hormone (ACTH) and cortisol suppression due to high doses or prolonged administration of glucocorticoids. While its chronic symptoms, such as fatigue and loss of appetite, are nonspecific, exposure to physical stressors, such as infection and surgery, increases the risk of adrenal crisis development accompanied by hypoglycemia, hypotension, or shock. The low-dose ACTH stimulation test is generally used for diagnosis, and the early morning serum cortisol level has also been shown to be useful in screening for the condition. Medical management includes gradually reducing the amount of steroid treatment, continuing administration of hydrocortisone corresponding to the physiological range, and increasing the dosage when physical stressors are present. Keywords: adrenal insufficiency; children; endocrinology; glucocorticoids; hypothalamic–pituitary –adrenal axis; therapeutics 1. Mainstem Concepts of Adrenal Insufficiency 1.1. Primary, Secondary, and Tertiary Adrenal Insufficiency Adrenal insufficiency (AI) is defined as the inability of the adrenal cortex to produce sufficient amounts of glucocorticoid hormone. It can also be associated with mineralocorticoid deficiency, depending on the pathophysiology of the disease [1]. Severe AI, or adrenal crisis, can be life-threatening because glucocorticoids and mineralocorticoids play a central role in maintaining energy, salt, and fluid homeostasis [2].
    [Show full text]